Bausch Health Companies BHC Insider Ownership

NYSE BHC

$6.16 -0.26 (-4.12%)

As of: Sep 9, 2026 · 3:59 PM EDT

Insider Holdings by Owner

79.01Mn Shares

Insider Ownership Statistics

as of 31 Mar, 2023

Insider Ownership

0.0098%

▼0.0000% pp QoQ

Shares Held by Insiders

35.49K

filed for Mar 2023

■0.00% QoQ

Shares Outstanding

375.50Mn

375,500,000 shares

Direct Holdings

35.49K

Indirect: 0

Net Shares Traded (QoQ)

no net change in Mar 2023

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Quarter ending 31 Mar, 2023

Bausch Health Companies's top three insider shareholders as of September 09, 2026 are John Paulson (Director, 70.76Mn shares), Thomas Appio (Chief Executive Officer, 2.32Mn shares), Joseph C Papa (Chairman Ceo, 1.43Mn shares).

A detailed ownership breakdown for Bausch Health Companies is not available at this time.
Insider shares in Bausch Health Companies do not amount to a significant value as of September 09, 2026.
Bausch Health Companies's count of insider shares amounted to 0 as of September 09, 2026.
Among Bausch Health Companies's top brass, John Paulson (Director) was the biggest buyer, purchasing 12.68K shares during the 90-day period from June 11, 2026 to September 09, 2026.
On the selling side, Aimee J. Lenar (President, Us Pharma) led at Bausch Health Companies with 65.48K shares sold during the same 90-day period ending September 09, 2026.

Form 4 Holdings

Insiders Holding BHC

Insiders 23

Shares held 79.01Mn

Of outstanding 21.04%

#	Insider	Position	Direct	Indirect	Total	Share of Insiders	Last Filed
1	John Paulson	Director	430,242	70,755,869	71,186,111	90.1%	02 Jul, 2026
2	Thomas Appio	Chief Executive Officer	2,315,374	0	2,315,374	2.9%	03 Mar, 2026
3	Joseph C Papa	Chairman Ceo	1,427,568	0	1,427,568	1.8%	12 May, 2022
4	Seana Carson	Evp, General Counsel	616,761	0	616,761	0.8%	03 Mar, 2026
5	Tom George Vadaketh	Evp, Chief Financial Officer	564,933	0	564,933	0.7%	06 Sep, 2023
6	Aimee J. Lenar	President, Us Pharma	334,853	0	334,853	0.4%	20 Aug, 2026
7	Amy B Wechsler	Director	314,979	0	314,979	0.4%	02 Jul, 2026
8	Robert N Power	Director	300,594	0	300,594	0.4%	26 May, 2026
9	Sarah B Kavanagh	Director	282,230	0	282,230	0.4%	26 May, 2026
10	Steven D Miller	Director	229,224	0	229,224	0.3%	20 May, 2025
11	Russel C Robertson	Director	225,279	0	225,279	0.3%	01 Apr, 2024
12	John S Barresi	Svp, Controller Cao	192,268	0	192,268	0.2%	03 Mar, 2025
13	Christina Ackermann	Evp And General Counsel	162,240	0	162,240	0.2%	11 Mar, 2022
14	Thomas W. Sr. Ross	Director	161,516	0	161,516	0.2%	19 May, 2023
15	Sam Eldessouky	Evp Chief Financial Officer	119,455	0	119,455	0.2%	07 Mar, 2022
16	Robert Spurr	President, U.S. Businesses	112,741	0	112,741	0.1%	12 May, 2022
17	Sandra Leung	Director	97,070	0	97,070	0.1%	02 Jul, 2026
18	Frank D. Lee	Director	95,210	0	95,210	0.1%	26 May, 2026
19	Joseph F Gordon	Presco Head Bauschlomb/Int'L	93,139	0	93,139	0.1%	10 Mar, 2022
20	Steven Hyosig Lee	Svp, Controller Cao	70,114	0	70,114	0.1%	15 Jul, 2026
21	Eiry Roberts	Director	45,871	0	45,871	0.1%	26 May, 2026
22	Eschenbach Andrew C. Von	Director	38,647	0	38,647	0.0%	09 Aug, 2021
23	Frederick Munsch	Svp, Controller And Cao	22,435	0	22,435	0.0%	05 May, 2022

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

2,651 Insider Transactions

Source SEC Form 4

Latest quarter Mar 2023

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
19 Aug, 2026	Aimee J. Lenar	President, Us Pharma	Disposed S	36,827	$7.03	$258.89K	334,853	Direct
17 Jul, 2026	Aimee J. Lenar	President, Us Pharma	Disposed F	5,260	$4.83	$25.41K	371,680	Direct
15 Jul, 2026	Aimee J. Lenar	President, Us Pharma	Disposed F	23,395	$4.89	$114.40K	376,940	Direct
14 Jul, 2026	Steven Hyosig Lee	Svp, Controller Cao	Disposed F	3,125	$4.75	$14.84K	70,114	Direct
30 Jun, 2026	Amy B Wechsler	Director	Acquired A	1,394	$4.93	$6.87K	314,979	Direct
30 Jun, 2026	John Paulson	Director	Acquired A	12,677	$4.93	$62.50K	430,242	Direct
30 Jun, 2026	Sandra Leung	Director	Acquired A	6,845	$4.93	$33.75K	97,070	Direct
22 May, 2026	Robert N Power	Director	Acquired A	45,871	$0.00	$0	300,594	Direct
22 May, 2026	Eiry Roberts	Director	Acquired A	45,871	$0.00	$0	45,871	Direct
22 May, 2026	John Paulson	Director	Acquired A	45,871	$0.00	$0	417,565	Direct
22 May, 2026	Frank D. Lee	Director	Acquired A	45,871	$0.00	$0	95,210	Direct
22 May, 2026	Amy B Wechsler	Director	Acquired A	45,871	$0.00	$0	313,585	Direct
22 May, 2026	Sandra Leung	Director	Acquired A	45,871	$0.00	$0	90,225	Direct
22 May, 2026	Sarah B Kavanagh	Director	Acquired A	45,871	$0.00	$0	282,230	Direct
19 May, 2026	Frank D. Lee	Director	Disposed S	24,456	$5.43	$132.80K	49,339	Direct
31 Mar, 2026	John Paulson	Director	Acquired A	11,574	$5.40	$62.50K	371,694	Direct
31 Mar, 2026	Amy B Wechsler	Director	Acquired A	1,273	$5.40	$6.87K	267,714	Direct
31 Mar, 2026	Sandra Leung	Director	Acquired A	5,946	$5.40	$32.11K	44,354	Direct
27 Feb, 2026	Seana Carson	Evp, General Counsel	Disposed F	26,326	$5.93	$156.11K	782,932	Direct
27 Feb, 2026	Seana Carson	Evp, General Counsel	Disposed F	26,326	$5.93	$156.11K	782,932	Direct

Showing 1 to 20 of 2,651 transactions